↓ Skip to main content

Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review

Overview of attention for article published in Frontiers in oncology, November 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
3 Mendeley